Upper Limb Spasticity - Revance

RVNC.O -, Stock Price & Latest News

Barclays Maintains Revance Therapeutics (RVNC) Overweight Recommendation

Revance Names Nashville Its New Home - Modern Aesthetics

Revance Announces U.S. FDA Acceptance of Supplemental Biologics License Application (sBLA) for DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study

Toxins, Free Full-Text

What's New on Interventions for Lower Limb Spasticity? (Transcript)

Upper Limb Spasticity Treatment For Adults

Botulinum toxin a in upper limb spasticity management: Baseline data from the upper limb international spasticity (ULIS)–III study - ScienceDirect

DaxibotulinumtoxinA Aims to Be Next Big Post-Stroke Spasticity Treatment

Revance Therapeutics (NASDAQ:RVNC) Trading Up 4%